HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michiel S Van Der Heijden Selected Research

Michiel S Van Der Heijden Research Topics

Disease

5Carcinoma (Carcinomatosis)
12/2023 - 11/2019
5Neoplasms (Cancer)
10/2022 - 11/2019
3Urinary Bladder Neoplasms (Bladder Cancer)
10/2022 - 01/2021
2Disease Progression
01/2022 - 01/2021
1Tertiary Lymphoid Structures
10/2022
1Infections
10/2022
1Fatigue
01/2021
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
06/2004

Drug/Important Bio-Agent (IBA)

7atezolizumabIBA
12/2023 - 11/2019
4Biomarkers (Surrogate Marker)IBA
12/2023 - 11/2019
2Immune Checkpoint InhibitorsIBA
10/2022 - 09/2021
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2021
2B7-H1 AntigenIBA
01/2021 - 01/2021
1ChemokinesIBA
10/2022
1pembrolizumabIBA
10/2022
1Transaminases (Aminotransferases)IBA
01/2021
1NivolumabIBA
01/2021
1bempegaldesleukinIBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
11/2019
1Mitomycin (Mitomycin-C)FDA LinkGeneric
06/2004

Therapy/Procedure

3Cystectomy
01/2022 - 11/2019
2Therapeutics
09/2021 - 01/2021
1Immunomodulation
10/2022
1Immunotherapy
01/2022
1Drug Therapy (Chemotherapy)
01/2021
1Aftercare (After-Treatment)
11/2019